Advertisement

Endovascular Management of Non-Healing Leg Ulceration

  • Jean Starr
  • Patrick Vaccaro
Chapter

Case Report

A 72 year old non-smoking female with a past medical history of hypertension, well-controlled diabetes, and stable coronary artery disease, status post CABG with bilateral great saphenous vein harvests, presents to her podiatrist. She developed an ulcer over the right first metatarsal head after wearing a new pair of shoes approximately 4 months ago. The wound is gradually getting larger, despite appropriate local wound care and off-loading procedures. She is referred to you for evaluation for arterial insufficiency.

Physical examination reveals normal and equal bilateral femoral pulses with no palpable distal pulses. There are well-healed, bilateral medial thigh incisions. The toes are pink with brisk capillary refill. There is diminished sensation to fine touch bilaterally, but normal motor function is noted. The ulcer base is pale with fibrinous debris. There is no foul odor or obvious cellulitis.

Question 1

The best first step in her evaluation and/or management is:
  1. A.

    O...

References

  1. 1.
    Hingorani A, Ascher E, Marks N. Preprocedural imaging: new options to reduce need for contrast angiography. Semin Vasc Surg. 2007;20(1):15–28.CrossRefPubMedGoogle Scholar
  2. 2.
    Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol. 2007;2:264–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Ouwendijk R, Kock MC, van Dijk LC, et al. Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors. Radiology. 2006;241(2):603–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.CrossRefPubMedGoogle Scholar
  5. 5.
    Ramsey DE, Manke DA, Sumner DS. Toe blood pressure. A valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg. 1983;24(1):43–8.Google Scholar
  6. 6.
    Nicholas GG, Myers JL, WE DM Jr. The role of vascular laboratory criteria in the selection of patients for lower extremity amputation. Ann Surg. 1982;195(4):469–73.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Deane CR, Needleman L. The cause of pulsus tardus in arterial stenosis. Radiology. 1995;194(1):28–30.CrossRefPubMedGoogle Scholar
  8. 8.
    Dormandy JA, Rutherford RB. Management of Peripheral Arterial Disease (PAD). TASC Working Group. TransAtlantic Intersociety Concensus (TASC). J Vasc Surg. 2000;31(1 part 2):S1–S296.PubMedGoogle Scholar
  9. 9.
    TASC II Working Group, Norgren L, Hiatt WR, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67.Google Scholar
  10. 10.
    Reichman W, Nichols B, Toner J, Jenvey W, Sobel M. Strategies in the treatment of major tissue loss and gangrene: results of 100 consecutive vascular reconstructions. Ann Vasc Surg. 1990;4(3):233–7.CrossRefPubMedGoogle Scholar
  11. 11.
    BASIL trial participants, Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicenter, randomized controlled trial. Lancet. 2005;366(9501):1925–34.CrossRefGoogle Scholar
  12. 12.
    Haider SN, Kavanagh EG, Forlee M, et al. Two-year outcome with preferential use of infrainguinal angioplasty for critical ischemia. J Vasc Surg. 2006;43(3):504–12.CrossRefPubMedGoogle Scholar
  13. 13.
    Giles KA, Pomposelli FB, Hamdan AD, et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg. 2008;48(1):128–36.CrossRefPubMedGoogle Scholar
  14. 14.
    Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. NEJM. 2006;354(18):1879–88.CrossRefPubMedGoogle Scholar
  15. 15.
    Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized multi-center study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral occlusive disease. J Vasc Interv Radiol. 2008;19(6):823–32.CrossRefPubMedGoogle Scholar
  16. 16.
    Shammas NW. Restenosis after lower extremity interventions: current status and future directions. J Endovasc Ther. 2009;16(Supp 1):170–82.Google Scholar
  17. 17.
    Brown DA, Lee EW, Loh CT, Kee ST. A new wave in the treatment of vascular occlusive disease: Biodegradable stents—animal experience and scientific principles. J Vasc Interv Radiol. 2009;20(3):315–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Personalized Health Care Expert Panel Meeting: Summary Report. Submitted to US Department of Health and Human Services by the Lewin Group, Inc. Sept. 10, 2007.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Vascular Diseases and SurgeryThe Ohio State UniversityColumbusUSA

Personalised recommendations